−3.59 M EUR
0.00 EUR
About TRYP THERAPEUTICS INC
Sector
CEO
Jason Carroll
Headquarters
Kelowna
Website
Founded
2019
FIGI
BBG00YVVL614
Tryptamine Therapeutics Limited is a clinical-stage biotechnology company focused on bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments. Tryptamine Therapeutics intends to accomplish this through the development of an IV infusion of psilocin (the active metabolite of psilocybin) which addresses many of the current limitations associated with orally administered psilocybin used by the majority of competitors in the field. Tryp’s lead programs are designed to address neuropsychiatric disorders through the therapeutic dosing of synthetic psilocybin and IV infused psilocin in conjunction with psychotherapy.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 8FW is 0.04 EUR — it hasn't changed in the past 24 hours. Watch TRYP THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange TRYP THERAPEUTICS INC stocks are traded under the ticker 8FW.
8FW stock is 0.00% volatile and has beta coefficient of −38.40. Track TRYP THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is TRYP THERAPEUTICS INC there?
Yes, you can track TRYP THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
No, 8FW doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 8FW shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TRYP THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TRYP THERAPEUTICS INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TRYP THERAPEUTICS INC stock shows the sell signal. See more of TRYP THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.